Ads
    Related paper
  1. Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon
  2. Intravitreal Bevacizumab Injection Effect in Exudative Age Related Macular Degeneration
  3. Analyse the Efficacy and Safety of Intravitreal Injection of Biosimilar Ranibizumab on Central Macular Thickness and Visual Outcome in Patients of Macular Edema
  4. Assessment of Macular Function by Multifocal Electroretinogram after Intravitreal Injection of Bevacizumab in Diabetic Macular Edema
  5. INTRAVITREAL BEVACIZUMAB AIDS REDUCTION OF MACULAR EDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION (CRVO)
  6. COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDY
  7. Efficacy of dorzolamide-timolol combination as an adjunct to Intravitreal Bevacizumab in treatment of macular edema due to retinal vein occlusion
  8. Retinal Pigment Epithelium Tear Following Intravitreal Bevacizumab Treatment for Choroidal Neovascular Membrane without Previous Pigment Epithelium Detachment: (Case Report)
  9. Association between CX3CR1 rs3732378 polymorphism and neovascular age-related macular degeneration in a sample of Algerian population
  10. Real Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration: A Subgroup Analysis of Pooled Retrospective RE-ENACT Study